Phase 3 results for Bharat Biotech's coronavirus vaccine - Covaxin - were released Wednesday afternoon, with the drug demonstrating "81 per cent interim efficacy in preventing COVID-19 in those without prior infection after the second dose", according to a statement by the company.
India reported 14,989 fresh COVID-19 cases on Wednesday - 22 per cent higher than Tuesday - taking the tally to 1,11, 39,516, according to the health ministry data this morning. The active cases were recorded above 1.7 lakh after a month, the data stated.
The death count increased to 1,57,346 with 98 daily new fatalities, the data updated at 8 am showed.
The COVID-19 active caseload has increased to 1,70,126 which comprises 1.53 per cent of the total infections, it stated.
The Centre has deputed teams to Tamil Nadu and Punjab following surge in COVID-19 cases across various states in the country.
India on Tuesday had reported 12,286 fresh coronavirus cases and the tally climbed to 1,11,24,527, while the number of recoveries has surged to 1,07,98,921.